Literature DB >> 1702089

Preoperative versus postoperative irradiation in the prophylaxis of heterotopic bone formation in rats.

D A Kantorowitz1, G J Miller, J A Ferrara, G S Ibbott, R Fisher, C R Ahrens.   

Abstract

Irradiation treatment, commenced within 1-5 days post-surgery, reliably prophylaxes heterotopic bone formation but is painful and impairs desirable postop immobilization. To compare pre- versus post-op radiation, we bilaterally implanted bone matrix pellets into the thighs of 111 30-day-old Long Evans rats. Rats were randomized to time of radiation initiation (2 days pre-op, 1 hr pre-op, or 2 days post-op) and dose (300, 800, 1800, 2400, or 3000 cGy in 1 fraction). Pellets were removed on post-op day 16 or 48 and evaluated histologically and radiologically. Histologic analysis showed dose-related suppression in bone formation, that is, 40%, 27%, 6.8%, 2.5%, 6.4%, and 0.0% bone formed among sites receiving 0, 300, 800, 1800, 2400, and 3000 cGy, respectively. The difference in bone formation between control and irradiated implant sites was significant at every dose level in all treatment groups (p less than or equal to .03). There was no statistically significant difference in overall bone formation between post-op (7.1%) and 1 hr pre-op (5.3%) groups, whereas 2 day pre-op rats formed significantly more bone (12.6%). Stratified by dose, however, there were no significant differences between treatment groups except at 800 cGy. At this dose, 2 day pre-op rats formed more bone (10.6%) than 1 hr pre-op (6.6%) or post-op (3.3%) groups. Results suggest that a) radiation given shortly prior to a stimulus inducing proliferation among multipotential cells may inhibit subsequent proliferation and/or differentiation, and b) clinical formation of heterotopic bone may be preventable via modest doses of irradiation delivered shortly prior to surgery.

Entities:  

Mesh:

Year:  1990        PMID: 1702089     DOI: 10.1016/0360-3016(90)90355-n

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  7 in total

1.  [Radiation therapy to prevent heterotopic ossification: example of a clinical trial].

Authors:  M H Seegenschmiedt
Journal:  Strahlenther Onkol       Date:  1997-12       Impact factor: 3.621

2.  Heterotopic bone formation about the hip undergoes endochondral ossification: a rabbit model.

Authors:  Oliver Tannous; Alec C Stall; Cullen Griffith; Christopher T Donaldson; Rudolph J Castellani; Vincent D Pellegrini
Journal:  Clin Orthop Relat Res       Date:  2013-01-30       Impact factor: 4.176

Review 3.  [Value of a combined ossification prophylaxis with indomethacin and radiotherapy for acetabular fractures].

Authors:  S Piatek; T Westphal; D Arbter; S Winckler
Journal:  Unfallchirurg       Date:  2006-07       Impact factor: 1.000

4.  [Prospective study on the prevention of heterotopic ossification after total hip replacement. Non-steroidal anti-inflammatory agents versus radiation therapy].

Authors:  O Kölbl; M Flentje; J Eulert; T Barthel; D Knelles; U Kraus
Journal:  Strahlenther Onkol       Date:  1997-12       Impact factor: 3.621

5.  Perioperative high-dose-rate brachytherapy in the treatment of recurrent malignant gliomas.

Authors:  Maria Grazia Fabrini; Franco Perrone; Lucia De Franco; Francesco Pasqualetti; Silvia Grespi; Riccardo Vannozzi; Luca Cionini
Journal:  Strahlenther Onkol       Date:  2009-08-04       Impact factor: 3.621

6.  Prevention of heterotopic ossification in hip arthroplasties by means of an early single-dose radiotherapy (6 Gy).

Authors:  P Schai; R Brunner; E Morscher; K H Schubert
Journal:  Arch Orthop Trauma Surg       Date:  1995       Impact factor: 3.067

7.  Experimental model of heterotopic ossification in Wistar rats.

Authors:  T G G Zotz; J B de Paula; A D L Moser
Journal:  Braz J Med Biol Res       Date:  2012-03-15       Impact factor: 2.590

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.